课题基金 / 基金详情

项目摘要

项目成果

DAVID M RAND的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):衰老的主要原因被认为是线粒体中产生的氧化磷酸化(OXPHOS)的副产物活性氧物种(ROS)。增加ROS清除或减少ROS产生的操作在某些系统中延长了寿命,但不是所有系统。卡路里或饮食限制(CR或DR)仍然是迄今为止在所有被研究的生物体中延长寿命的最可重复的单一干预措施。最近的研究已经确定了CR或DR、线粒体功能改变和延长寿命之间的关系。在这项建议中,我们提出了明确的证据表明,mtDNA单倍型1)可以延长或缩短寿命,2)修改饮食限制的延长寿命的效果,3)修改胰岛素受体底物突变chico1的延长寿命的效果。这些发现为核线粒体DNA上位性作图在揭示饮食限制延长寿命的遗传机制方面的有效性提供了原则性证据。这些结果导致了一种假设,即线粒体DNA中编码的基因对营养相关的长寿修饰至关重要。我们将利用这些mtDNA替换菌株,通过Rpd3-Sir2和TOR通路的上位性实验来验证这一假说,这些通路在基于营养的长寿变化中发挥重要作用。这些基因结构还将被用来检验mtDNA基因型通过改变氧化损伤水平来改变寿命这一普遍假设。有三个特定的目标将检验这些假设:1)mtDNA基因型是否会改变依赖Rpd3的寿命延长?我们将检验线粒体基因改变RPD3对寿命的影响,以及RPD3‘S独立于博士的假设。2)线粒体DNA基因型是否改变饮食限制对Sir2的依赖效应?我们将通过将mtDNA与不同饮食中的过度表达和组织特异性表达结构配对,来检验mtDNA基因改变Sir2在调节对DR的反应中所起的作用的假设。3)mtDNA基因是否改变了TOR通路对营养感知和寿命延长的影响?我们将通过将mtDNA与TOR和TSC2基因的亚型和组织特异性表达结构配对来检验这一假设,即mtDNA基因改变了TOR和TSC2在延长寿命方面所起的作用。与公共健康相关:这些实验将提供关于特定线粒体基因组如何与确定的核基因相互作用的基本信息,以确定长寿和对长寿的饮食调节。由于这些相互作用在进化上是古老的和高度保守的,对果蝇影响衰老的遗传途径的解剖将对理解这种衰老和人类的衰老相关疾病非常相关。
英文摘要
DESCRIPTION (provided by applicant): A primary cause of aging is thought to be reactive oxygen species (ROS) produced in mitochondria as byproducts of oxidative phosphorylation (OXPHOS). Manipulations that either increase ROS scavenging or decrease ROS production have extended longevity in some, but not all systems. Caloric or dietary restriction (CR or DR) remains the single most repeatable intervention that extends longevity in all organisms studied to date. Recent studies have identified a relationship between CR or DR, altered mitochondrial function, and extended longevity. In this proposal we present clear evidence that mtDNA haplotypes 1) can extend or shorten longevity, 2) modify the longevity-extending effects of diet restriction, 3) modify the longevity-extending effects of the insulin receptor substrate mutation chico1. These findings provide proof of principle that nuclear-mtDNA epistasis mapping is effective in uncovering genetic mechanisms of longevity extension by diet restriction. The results lead to the hypothesis that genes encoded in mtDNA are critical for the nutrient-dependent modification of longevity. We will exploit these mtDNA replacement strains to test this hypothesis using epistasis experiments with the Rpd3 - Sir2 and TOR pathways that play important roles in nutrient-based changes in longevity. These genetic constructs will also be used to test the general hypothesis that mtDNA genotype modifies longevity through changes in the level of oxidative damage. There are three specific aims that will test each of these hypotheses: 1) Does mtDNA genotype alter the Rpd3-dependent extension of longevity? We will test the hypothesis that mitochondrial genes modify the effect of Rpd3 on longevity, and Rpd3's independence from DR. 2) Does mtDNA genotype alter the Sir2-dependent effects of dietary restriction? We will test the hypothesis that mtDNA genotype modifies the role Sir2 plays in regulating the response to DR by pairing mtDNAs with over-expression and tissue specific expression constructs on different diets. 3) Does mtDNA genotype modify the TOR pathway effects on nutrient sensing and longevity extension? We will test the hypothesis that mtDNA genotype modifies the role that TOR and Tsc2 play in extending longevity by pairing mtDNAs with hypomorphic and tissue specific expression constructs of these genes. PUBLIC HEALTH RELEVANCE: These experiments will provide fundamental information on how specific mitochondrial genomes interact with defined nuclear genes to determine longevity and the dietary modulation of longevity. As these interactions are evolutionarily ancient and highly conserved, the dissection of genetic pathways affecting aging in Drosophila will be very relevant to understanding this aging and age-related diseases in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitonuclear genetics of complex traits in Drosophila
  • 批准号:
    10594405
  • 项目类别:
  • 资助金额:
    $38.55万
  • 财政年份:
    2021
  • 负责人:
    DAVID M RAND
  • 依托单位:
Mitonuclear genetics of complex traits in Drosophila
  • 批准号:
    10377905
  • 项目类别:
  • 资助金额:
    $38.58万
  • 财政年份:
    2021
  • 负责人:
    DAVID M RAND
  • 依托单位:
Admin Core
  • 批准号:
    10681233
  • 项目类别:
  • 资助金额:
    $48.99万
  • 财政年份:
    2016
  • 负责人:
    DAVID M RAND
  • 依托单位:
COBRE: Center for Computational Biology of Human Disease
  • 批准号:
    10461166
  • 项目类别:
  • 资助金额:
    $229.51万
  • 财政年份:
    2016
  • 负责人:
    DAVID M RAND
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: